The celiac iceberg: characterization of the disease in primary schoolchildren

J Pediatr Gastroenterol Nutr. 2013 Apr;56(4):416-21. doi: 10.1097/MPG.0b013e31827b7f64.

Abstract

Objective: Celiac disease (CD) has a prevalence of 0.55% to 1% in Italy. Identifying CD in schoolchildren to characterize CD iceberg and evaluate the effect of diagnosis in screening-detected children.

Methods: A total of 7377 5- to 8-year-old children were invited to participate. A total of 5733 salivary samples were collected and tested for anti-transglutaminase antibodies (tTGAb), using a fluid-phase radioimmunoassay. Salivary tTGAb-positive children were analyzed for serum antibodies (anti-endomysium antibodies, radioimmunoassay, and enzyme-linked immunosorbent assay tTGAb). Positive children underwent endoscopy and then started gluten-free diet (GFD) and periodical follow-up.

Results: Forty-six subjects were found salivary tTGAb-positive and 16 border-line. Forty-five of 46 and 5 of 15 of them were also serum antibody-positive. Forty-two children showed duodenal villous atrophy and 1 had only type 1 lesions. Three children started GFD without performing endoscopy. CD prevalence (including 23 previously diagnosed children with CD) was 1.2%. Considering all 65 celiacs in our sample, a silent CD was found in 64%, typical in 28%, atypical in 7%, and potential in 1%. All patients showed strict adherence to GFD, weight and stature increase, and well-being improvement. Eighty-five percent and all but 2 screening-detected children with CD had Italian parents.

Conclusions: Our sample size, representative of primary schoolchildren of our region, demonstrated that CD prevalence is growing in Italy, with a modified clinical spectrum and iceberg deepness.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Atrophy
  • Autoantibodies / analysis
  • Celiac Disease / diet therapy*
  • Celiac Disease / epidemiology*
  • Celiac Disease / immunology
  • Celiac Disease / pathology
  • Child
  • Child, Preschool
  • Cohort Studies
  • Diet, Gluten-Free*
  • Duodenum / immunology
  • Duodenum / pathology
  • Early Diagnosis
  • Female
  • Follow-Up Studies
  • Humans
  • Intestinal Mucosa / immunology
  • Intestinal Mucosa / pathology
  • Italy / epidemiology
  • Male
  • Mass Screening
  • Prevalence
  • Saliva / immunology
  • Severity of Illness Index
  • Transglutaminases / antagonists & inhibitors

Substances

  • Autoantibodies
  • Transglutaminases